Skip to main content

Table 3 Significant differences in the microbial distribution of taxa (phylum and genus) in patients with inflammatory bowel disease in remission with IBS-type symptoms

From: Fecal microbiota profiling in irritable bowel syndrome and inflammatory bowel disease patients with irritable bowel syndrome-type symptoms

  IBS CDR-IBS+ CDR-IBS UCR-IBS+ UCR-IBS CDR-IBS+ vs UCR-IBS+ CDR-IBS vs UCR-IBS CDR-IBS+ vs IBS UCR-IBS+ vs IBS CDR-IBS+ vs CDR-IBS UCR-IBS+ vs UCR-IBS
Bacteroidetes            
Butyricimonas ⬆b   ⬇a   ⬇a     a   
Odoribacter    ⬇b   ⬇a       
Firmicutes            
Enterococcus   ⬆b ⬆b ⬆a ⬆a    ⬆a    
Clostridium   ⬆c      b     
Lachnospira    ⬇a     b     
Faecalibacterium    ⬇b     a    b  
Megasphaera   ⬆b ⬆b ⬆a ⬆a       
Ruminofilibacter     ⬆c   b    c   
Gemmiger   b         
Proteobacteria            
Sutterella    ⬇a ⬇a        
Desulfovibrio    ⬇b ⬇b ⬇a     a   
Actinobacteria            
Actinomyces   ⬆a ⬆c ⬆a    b     
Fusobacteria            
Fusobacterium ⬆b   ⬆c     b   b   
Verrucomicrobia            
Akkermansia    ⬇a ⬇b   a      
  1. ⬆ and ⬇ relative to the controls. CD Crohn’s disease, CDR Crohn’s disease in remission, CDR-IBS+ CDR with IBS-type symptoms, CDR-IBS CDR without IBS-type symptoms. UC ulcerative colitis, UCR ulcerative colitis in remission, UCR-IBS+ UCR with IBS-type symptoms, UCR-IBS UCR without IBS-type symptoms. aP < 0.05; bP < 0.001; cP < 0.001